Primary Sjögren Syndrome
Pipeline by Development Stage
Competitive Landscape
6 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (6)
Total enrollment: 521 patients across 6 trials
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Primary Sjogren Syndrome
A Study of RSLV-132 in Females With Sjögren's Disease
A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS)
68Ga-P16-093 PET/CT Imaging in the Salivary Gland
Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome
Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.